Age at HPV vaccine initiation and completion among US adolescent girls: Trend from 2008 to 2012

Vaccine

Volumn 33, Issue 5, 2015, Pages 585-587

  Rahman, Mahbubur ^a   McGrath, Christine J ^a   Hirth, Jacqueline M ^a   Berenson, Abbey B ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Adolescent girls; Age at vaccine completion; Age at vaccine initiation; HPV vaccine; Human papillomavirus (HPV)

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; AGE; ARTICLE; CHILD; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES; VACCINATION; AGE DISTRIBUTION; CROSS-SECTIONAL STUDY; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; UTILIZATION;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UNITED STATES; VACCINATION;

EID: 84921313515     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.12.021     Document Type: Article

References (15)

1. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
2. Garland S.M., Steben M., Sings H.L., James M., Lu S., Railkar R., et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009, 199:805-814.
3. Bosch F.X., Burchell A.N., Schiffman M., Giuliano A.R., de Sanjose S., Bruni L., et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008, 26(Suppl. 10):K1-K16.
4. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al. Prevalence of HPV infection among females in the United States. JAMA 2007, 297(8):813-819.
5. Centers for Disease Control and Prevention FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendation from the Advisory Committee on Immunization Practices (ACIP). MMWR 2010, 59:626-629.
6. U.S.Department of Health and Human Services (DHHS), National Center for Health Statistics The 2011 National Immunization Survey - Teen 2012, Centers for Disease Control and Prevention, Hyattsville, MD.
7. U.S.Department of Health and Human Services (DHHS), National Center for Health Statistics The 2008 National Immunization Survey - Teen 2009, Centers for Disease Control and Prevention, Hyattsville, MD.
8. U.S.Department of Health and Human Services (DHHS), National Center for Health Statistics The 2009 National Immunization Survey - Teen 2010, Centers for Disease Control and Prevention, Hyattsville, MD.
9. U.S.Department of Health and Human Services (DHHS), National Center for Health Statistics The 2010 National Immunization Survey - Teen 2011, Centers for Disease Control and Prevention, Hyattsville, MD.
10. U.S.Department of Health and Human Services (DHHS), National Center for Health Statistics The 2012 National Immunization Survey - Teen 2013, Centers for Disease Control and Prevention, Hyattsville, MD.
11. Cullen K.A., Stokley S., Markowitz L.E. Uptake of human papillomavirus vaccine among adolescent males and females: immunization information system sentinel sites, 2009-2012. Acad Pediatr 2014, 14:497-504.
12. Kahn J.A., Ding L., Huang B., Zimet G.D., Rosenthal S.L., Frazier A.L., et al. Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics 2009, 123:1439-1445.
13. Daley M.F., Crane L.A., Markowitz L.E., Black S.R., Beaty B.L., Barrow J., et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010, 126:425-433.
14. Vadaparampil S.T., Kahn J.A., Salmon D., Lee J.H., Quinn G.P., Roetzheim R., et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine 2010, 29:8634-8641.
15. Dempsey A., Cohn L., Dalton V., Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine 2010, 28:989-995.